These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3661295)

  • 1. Atrial fibrillation and stroke: the view from neurology.
    Sherman DG
    Adv Exp Med Biol; 1987; 214():283-9. PubMed ID: 3661295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and management of acute stroke in patients with atrial fibrillation admitted to US university hospitals.
    Albers GW; Bittar N; Young L; Hattemer CR; Gandhi AJ; Kemp SM; Hall EA; Morton DJ; Yim J; Vlasses PH
    Neurology; 1997 Jun; 48(6):1598-604. PubMed ID: 9191773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stroke prevention in nonvalvular atrial fibrillation: a review of prospective randomized trials.
    Albers GW; Sherman DG; Gress DR; Paulseth JE; Petersen P
    Ann Neurol; 1991 Oct; 30(4):511-8. PubMed ID: 1789680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early introduction of direct oral anticoagulants in cardioembolic stroke patients with non-valvular atrial fibrillation.
    Cappellari M; Carletti M; Danese A; Bovi P
    J Thromb Thrombolysis; 2016 Oct; 42(3):393-8. PubMed ID: 27329483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation for atrial fibrillation: epidemiology informing a difficult clinical decision.
    Singer DE
    Proc Assoc Am Physicians; 1996 Jan; 108(1):29-36. PubMed ID: 8834062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of thromboembolic events in atrial fibrillation.
    Koefoed BG; Gulløv AL; Petersen P
    Thromb Haemost; 1997 Jul; 78(1):377-81. PubMed ID: 9198182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for stroke and thromboembolism in relation to age among patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project.
    Olesen JB; Fauchier L; Lane DA; Taillandier S; Lip GYH
    Chest; 2012 Jan; 141(1):147-153. PubMed ID: 21680645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Non valvular atrial fibrillation: the neurologist's perspective].
    Cunha L
    Rev Port Cardiol; 2012 Apr; 31 Suppl 1():27-31. PubMed ID: 22541032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiogenic stroke.
    Hart RG
    Am Fam Physician; 1989 Nov; 40(5 Suppl):35S-38S. PubMed ID: 2683693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventing stroke in atrial fibrillation.
    Wolf PA; Singer DE
    Am Fam Physician; 1997 Dec; 56(9):2242-50. PubMed ID: 9402810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stroke prevention in non-rheumatic atrial fibrillation.
    Duncan GW
    Tenn Med; 1997 Jan; 90(1):21-2. PubMed ID: 8997157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulation to prevent stroke in atrial fibrillation and its implications for managed care.
    Singer DE
    Am J Cardiol; 1998 Mar; 81(5A):35C-40C. PubMed ID: 9525571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detecting nonvalvular atrial fibrillation and anticoagulant therapy in cardioembolic ischemic stroke.
    Min J; Farooq MU
    Postgrad Med; 2016 Aug; 128(6):620-8. PubMed ID: 27263867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anticoagulation in aged patients with chronic non-rheumatic atrial fibrillation].
    Rodríguez D; Agustí A
    Med Clin (Barc); 1999 Mar; 112(11):436-7. PubMed ID: 10231778
    [No Abstract]   [Full Text] [Related]  

  • 15. Atrial fibrillation and stroke. Three new studies, three remaining questions.
    Albers GW
    Arch Intern Med; 1994 Jul; 154(13):1443-8. PubMed ID: 8017999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Net Clinical Benefit of Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Phase III Atrial Fibrillation Trials.
    Renda G; di Nicola M; De Caterina R
    Am J Med; 2015 Sep; 128(9):1007-14.e2. PubMed ID: 25910790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial cardiopathy: a broadened concept of left atrial thromboembolism beyond atrial fibrillation.
    Kamel H; Okin PM; Longstreth WT; Elkind MS; Soliman EZ
    Future Cardiol; 2015 May; 11(3):323-31. PubMed ID: 26021638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial fibrillation and stroke: elucidating a newly discovered risk factor.
    Giardina EG
    Am J Cardiol; 1997 Aug; 80(4C):11D-18D; discussion 35D-39D. PubMed ID: 9284039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice.
    Caro JJ; Flegel KM; Orejuela ME; Kelley HE; Speckman JL; Migliaccio-Walle K
    CMAJ; 1999 Sep; 161(5):493-7. PubMed ID: 10497604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioembolic stroke. Primary and secondary prevention.
    Anderson DC
    Postgrad Med; 1991 Dec; 90(8):67-72, 77. PubMed ID: 1749740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.